Tag: AstraZeneca
-
AstraZeneca’s Imfinzi approved in the European Union and the UK
•
LONDON: AstraZeneca‘s Imfinzi (durvalumab) has been approved in the European Union and the UK for an additional dosing…
-
AstraZeneca completes Atacand divestment to Cheplapharm in more than 70 countries
•
LONDON, UK: AstraZeneca has completed the divestment of commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (a…
-
AstraZeneca signs definitive agreement to acquire Alexion Pharmaceuticals
•
CAMBRIDGE: AstraZeneca and Alexion Pharmaceuticals Inc. have entered into a definitive agreement for AstraZeneca to acquire Alexion, a…
-
AstraZeneca sells Crestor to Grünenthal in Europe in a $320 million deal
•
LONDON: AstraZeneca has agreed to sell the rights to Crestor (rosuvastatin) and associated medicines in over 30 countries…
-
Lonza signs agreement to manufacture AstraZeneca’s COVID-19 treatment
•
BASEL: Lonza has signed an agreement with AstraZeneca to manufacture AZD7442, a combination of two long-acting antibodies (LAABs)…
-
AstraZeneca agrees to sell commercial rights to Atacand to Cheplapharm Arzneimittel GmbH
•
LONDON: AstraZeneca has agreed to sell the commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (a fixed-dose…
-
AstraZeneca’s COVID-19 long-acting antibody combination advances into Phase III clinical trials
•
LONDON: AstraZeneca’s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than…
-
AstraZeneca to list US ADR equity and all US debt securities on Nasdaq
•
LONDON: AstraZeneca today announced that it will be transferring the listing of its American Depositary Receipts (ADRs) and…
-
RenalytixAI, AstraZeneca to develop and launch precision medicine strategies
•
NEW YORK: Renalytix AI plc announced a collaboration with AstraZeneca to develop and launch precision medicine strategies for…
-
AstraZeneca announces a three-tranche $3 billion global bond offering
•
LONDON: AstraZeneca PLC announces that, on 3 August 2020, it priced a three tranche global bond offering totalling…
-
AstraZeneca and Daiichi Sankyo enter collaboration to develop and commercialise oncology treatment
•
LONDON: AstraZeneca has entered into a new global development and commercialisation agreement with Daiichi Sankyo Company Limited for…
-
AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine
•
LONDON: AstraZeneca has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.